Allakos Inc (ALLK)

May 16, 2025

Allakos stock hits 52-week low at $0.3 amid market challenges - MSN

May 16, 2025

May 16, 2025

Allakos completes merger with Concentra Biosciences By Investing.com - Investing.com South Africa

May 16, 2025

May 15, 2025

Allakos Completes Merger with Concentra Biosciences - TipRanks

May 15, 2025

May 15, 2025

Allakos completes merger with Concentra Biosciences - Investing.com

May 15, 2025

May 14, 2025

Allakos Inc.(NasdaqGS: ALLK) dropped from S&P TMI Index - marketscreener.com

May 14, 2025

May 06, 2025

Allakos Inc. (NASDAQ:ALLK) Shares Sold by Barclays PLC - Defense World

May 06, 2025

May 05, 2025

Allakos Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView

May 05, 2025

May 01, 2025

ALLK Shares Experience Decline in Value - knoxdaily.com

May 01, 2025

May 01, 2025

Renaissance Technologies LLC Has $1.02 Million Position in Allakos Inc. (NASDAQ:ALLK) - Defense World

May 01, 2025

Apr 30, 2025

Allakos Inc. (NASDAQ:ALLK) Short Interest Update - Defense World

Apr 30, 2025

Apr 28, 2025

Shareholder Alert: The Ademi Firm Investigates Whether SpringWorks Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Apr 28, 2025

Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025

Apr 22, 2025

Checking in on Allakos Inc (ALLK) after recent insiders movement - knoxdaily.com

Apr 22, 2025

Apr 04, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, HMST, ALLK, OPOF on Behalf of Shareholders - PR Newswire

Apr 04, 2025

Apr 03, 2025

Allakos Inc (ALLK) Recovers 48.96% From Low: Are We There Yet? - stocksregister.com

Apr 03, 2025

Apr 03, 2025

Allakos And 2 Other Promising Penny Stocks To Watch - simplywall.st

Apr 03, 2025

Apr 03, 2025

Short Interest in Allakos Inc. (NASDAQ:ALLK) Decreases By 13.9% - Defense World

Apr 03, 2025

Apr 02, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Allakos Inc.ALLK - PR Newswire

Apr 02, 2025

Apr 02, 2025

Concentra Biosciences, LLC entered into an agreement to acquire Allakos Inc. for $31 million. - marketscreener.com

Apr 02, 2025

Apr 02, 2025

Allakos Inc Inc. (ALLK) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 02, 2025

Apr 02, 2025

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Allakos, Inc. (ALLK) - TradingView

Apr 02, 2025

Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Apr 02, 2025

Apr 02, 2025

Tang Capital’s Concentra nabs a win, making a deal to buy Allakos - Endpoints News

Apr 02, 2025

Apr 02, 2025

Allakos to be acquired by Concentra Biosciences for 33c per share in cash - TipRanks

Apr 02, 2025

Apr 02, 2025

ALLK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Allakos Inc. Is Fair to Shareholders - The Joplin Globe

Apr 02, 2025

Apr 02, 2025

Allakos to Be Acquired by Concentra Biosciences for $0.33 per Share - MarketScreener

Apr 02, 2025

Apr 02, 2025

Allakos Announces Merger Agreement with Concentra Biosciences - TipRanks

Apr 02, 2025

Apr 02, 2025

Shareholder Alert: The Ademi Firm Investigates Whether Allakos Inc. Is Obtaining a Fair Price for Its Public Shareholders - Bluefield Daily Telegraph

Apr 02, 2025

Apr 02, 2025

Allakos agrees to Concentra Biosciences acquisition - Investing.com

Apr 02, 2025

Apr 02, 2025

Allakos surges on reverse merger deal with Concentra Biosciences - Seeking Alpha

Apr 02, 2025

Apr 02, 2025

Allakos to Be Acquired for 33 Cents a Share - MarketWatch

Apr 02, 2025

Apr 02, 2025

Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share - The Manila Times

Apr 02, 2025

Apr 02, 2025

Allakos Inc. Enters Into Agreement To Be Acquired By Concentra Biosciences - MarketScreener

Apr 02, 2025

Apr 02, 2025

Allakos (ALLK) Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share - StreetInsider

Apr 02, 2025

Apr 02, 2025

Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in - Bluefield Daily Telegraph

Apr 02, 2025

Apr 02, 2025

Biotech Deal Alert: Concentra Biosciences Acquires AllakosKey Terms Revealed - Stock Titan

Apr 02, 2025

Apr 01, 2025

ALLK ALERT: ROSEN, A LEADING FIRM, Reminds Allakos Inc. Investors of Important May 11th Deadline in Securities Class Action First Filed By Firm- ALLK - ACCESS Newswire

Apr 01, 2025

Mar 26, 2025

Allakos stock plunges to 52-week low of $0.23 amid market challenges By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Allakos stock plunges to 52-week low of $0.23 amid market challenges - Investing.com Australia

Mar 26, 2025

Mar 24, 2025

Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Mar 24, 2025

Mar 20, 2025

Shareholder Alert: The Ademi Firm investigates whether Optinose, Inc. is obtaining a Fair Price for its Public Shareholders - Business Wire

Mar 20, 2025

Mar 18, 2025

Analyzing Allakos (NASDAQ:ALLK) and Acerus Pharmaceuticals (OTCMKTS:TRLPF) - Defense World

Mar 18, 2025

Mar 17, 2025

Allakos Inc.: Hold Rating Amid Restructuring and Financial Uncertainty - TipRanks

Mar 17, 2025

Mar 14, 2025

Allakos faces potential Nasdaq delisting over share price By Investing.com - Investing.com India

Mar 14, 2025

Mar 14, 2025

Allakos Reports Q4 2024 Results Amid Strategic Shift - TipRanks

Mar 14, 2025

Mar 13, 2025

Allakos faces potential Nasdaq delisting over share price - Investing.com

Mar 13, 2025